Reverba

Helping patients invest in life sciences companies is an interesting strategy. We're going to stick with helping life sciences companies invest in patients.

Why a consulting firm focused life sciences bought a healthcare crowdsourcing platform Alira Health hopes its purchase of RedCrow will help it stand out from the crowd of consulting firms that help life sciences companies bring drugs to market.

“Give me the chance to say no after I’ve received all the information. Let me make that informed decision. Nobody’s telling us about clinical trials. Why is that?”

FDA and drug makers deepen their commitment to clinical-trial diversity. Will it work? After years of ‘lackluster’ efforts, regulators and companies are finally aligned in their goal to make clinical trials more representative of U.S. population.